Exercise alleviates depression related systemic inflammation in chronic obstructive pulmonary disease patients.

African Health Sciences

Volumn 16, Issue 4, 2016, Pages 1078-1088

  Abd El Kader, Shehab M ^a   Al Jiffri, Osama H ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Aerobic exercise; Chronic obstructive pulmonary disease; Depression; Inflammatory cytokine

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AEROBIC EXERCISE; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; SAUDI ARABIA; BLOOD; EXERCISE; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE;

ADULT; C-REACTIVE PROTEIN; DEPRESSION; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85014736772     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v16i4.25     Document Type: Article

References (71)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Ni-zankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370:741-50 PubMed .
2. Australian Institute of Health and Welfare. COPD (chronic obstructive pulmonary disease). cited 2013 Dec 28. Available online: http://www.aihw.gov.au/copd/
3. Global Strategy for the diagnosis, management and prevention of chronic obstruvtive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; Revised 2013. Available online: http://www.goldcopd. org/(accessed December 2013).
4. De S. Prevalence of Depression in Stable Chronic Obstructive Pulmonary Disease. Indian J Chest Dis Allied Sci 2011; 53:35-39
5. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F: Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2011; 17(Suppl 1):S21–S28.
6. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPD: Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134(4 Suppl):43S–56S. PubMed
7. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA: Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005;127(4):1205–1211. PubMed
8. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S: Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41(6):465– 471. PubMed
9. Cafarella PA, Effing TW, Usmani ZA, Frith PA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respi-rology 2012; 17:627-38 PubMed.
10. Pumar MI1, Gray CR1, Walsh JR1, Yang IA1, Rolls TA1, Ward DL1. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis 2014; 6(11):1615-31. PubMed
11. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 2013; 144:766-77 PubMed .
12. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122: 1633-7 PubMed.
13. Murali Mohan BV1, Sen T, Ranganath R. Systemic manifestations of COPD. J Assoc Physicians India 2012; 60 Suppl: 44-7.
14. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. Journal of Chronic Obstructive Pulmonary Disease 2005; 2:185-193
15. Hibare K, Kamalaksha S, Kalyani N, Asha P, Kirthana K, Murthy P, Murali Mohan BV. Depression in COPD – a depressingly frequent finding! Paper presented at NAP-CON 2003, Coimbatore
16. Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM. Increased stressinduced inflammatoryresponses in male patients with major depression and increased early life stress. Am J Psychiatry 2006; 163:1630-3 PubMed
17. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, Hansson O, Bjorkqvist M, Trask-man-Bendz L, Brundin L: Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009, 66:287–292. PubMed
18. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171–186. PubMed
19. Lu Y, Feng L, Feng L, Nyunt MS, Yap KB, Ng TP. Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir Res 2013;14:53.
20. Hiles SA, Baker AL, de Malmanche T, Attia J. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med 2012;42(10):2015–2026. PubMed
21. Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. International Journal of Psychiatry in Medicine 2011;41(1):15-28.
22. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007;69 (7):587–596. PubMed
23. Mead GE, Morley W, Campbell P, Greig CA, Mc-Murdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev. 2009;3:CD004366.
24. GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Scientific Committee http://www.goldcopd.org/, Retrieved on 12/01/2006.
25. Beck A, Ward C, Mendelson M. Beck depression inventory (BDI). Arch Gen Psychiatry 1961;4:561–571. PubMed
26. American College of Sports Medicine. Guidelines for graded exercise testing and exercise prescription, Lea & Febiger, Philadelphia, 2005.
27. Kochanek K, Xu J, Minino A. Deaths. preliminary data for 2009. National Center for Health Statistics, Hy-attsville, MD, 2011.
28. NHLBI Morbidity and Mortality Chart book. Available at: http://www.nhlbi.nih.gov/resources/docs/cht-bookhtm Accessed August 26, 2011.
29. Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
30. Rosenberg S, Kalhan R. Biomarkers in chronic obstructive pulmonary disease .Translational Research 2012; 159(4):228-237.
31. Chen H, Wang D, Bai C, Wang X. Proteomics-based biomarkers in chronic obstructive pulmonary disease. J Proteome Res 2010; 9:2798–808. PubMed
32. Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis 2014; 63: 799–804.
33. Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013;246:199–229. PubMed
34. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65(9):732– 41. PubMed
35. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71(2):171–86. PubMed
36. Dekker M, Lee S, Hudson R, Kilpatrick K, Graham T, Ross R. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 2007;56(3):332–8.
37. Mikkelsen U, Couppé C, Karlsen A, Grosset J, Schjer-ling P, Mackey A, Klausen H, Magnusson S, Kjær M. Lifelong endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev 2013;134(11-12):531-40. PubMed
38. Sugawara K, Takahashi H, Kashiwagura T, Yamada K, Yanagida S, Homma M, Dairiki K, Sasaki H, Kawag-oshi A, Satake M, Shioya T. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respiratory Medicine 2012; 106: 1526e1534
39. You T, Berman D, Ryan A, Nicklas B. Effects of hy-pocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 2004; 89(4):1739–46.
40. Larsen A, Aukrust P, Aarsland T, Dickstein K. Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. Am J Cardiol 2001; 88(7):805–8. PubMed
41. Giannopoulou I, Fernhall B, Carhart R, Weinstock R, Baynard T, Figueroa A, Kanaley J. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005; 54:866–75. PubMed
42. Troseid M, Lappegard KT, Mollnes T, Arnesen H, Seljeflot I. The effect of exercise on serum levels of in-terleukin-18 and components of the metabolic syndrome. Metab Syndr Relat Disord 2009;7(6):579-84.
43. Lakka T, Lakka H, Rankinen T, Leon A, Rao D, Skinner J, Wilmore J, Bouchard C. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005; 26:2018–25. PubMed
44. Beavers K, Brinkley T, Nicklas B. Effect of exercise training on chronic inflammation. Clin Chim Acta 2010; 411(11-12):785-93. PubMed
45. Scheele C, Nielsen S, Pedersen B. ROS and myokines promote muscle adaptation to exercise. Trends Endocrinol Metab 2009; 20:95–9.
46. Smith J, Dykes R, Douglas J, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing isch-emic heart disease. JAMA 1999; 281:1722–7. PubMed
47. Timmerman K, Flynn M, Coen P, Markofski M, Pence B. Exercise training induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol 2008; 84:1271–8. PubMed
48. Stewart L, Flynn M, Campbell W, Craig B, Robinson J, McFarlin B, Timmerman K, Coen P, Felker J, Talbert E. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun 2005; 19:389–97. PubMed
49. Apolzan J, Flynn M, McFarlin B, Campbell W. Physical activity status, but not age, influences inflammatory biomarkers and toll-like receptor 4. J Gerontol A Biol Sci Med Sci 2006; 61:388–93.
50. Gleeson M, McFarlin B, Flynn M. Exercise and toll-like receptors. Exerc Immunol Rev 2006; 12:34–53. PubMed
51. Sloan R, Shapiro P, Demeersman R, McKinley P, Tracey K, Slavov I, Fang Y, Flood P. Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 2007; 103:1007–11. PubMed
52. Garrod R, Ansley P, Canavan J, Jewell A. Exercise and the inflammatory response in chronic obstructive pulmonary disease (COPD)--Does training confer anti-inflammatory properties in COPD?. Med Hypotheses 2007; 68(2):291-8. PubMed
53. Woods J, Vieira V, Keylock K. Exercise, inflammation, and innate immunity. Neurol Clin 2006; 24(3):585– 99. PubMed
54. Mota-Pereira J, Silverio J, Carvalho S, Ribeiro JC, Fonte D, Ramos J. Moderate exerciseimproves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res 2011;45(8):1005-11. PubMed
55. Blumenthal JA, Emery CF, Madden DJ, George LK, Coleman RE, Riddle MW, McKee DC, Reasoner J, Williams RS. Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women. J Gerontol A Biol Sci Med Sci 1989;44:M147–57.
56. McNeil JK, LeBlanc EM, Joyner M. The effect of exercise on depressive symptoms in the moderately depressed elderly. Psychol Aging 1991;6:487–8. PubMed
57. Blumenthal JA, Babyak MA, Carney RM, Huber M, Saab PG, Burg MM, Sheps D, Powell L, Taylor CB, Kaufmann PG. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004:746–55.
58. Conn V. Depressive symptom outcomes of physical activity interventions: meta-analysis findings. Ann. Behav. Med 2010;39 (2):128–138. PubMed
59. Craft L. Exercise and clinical depression: examining twopsychological mechanisms. Psychology of Sport and Exercise 2005; 6(2):151-171.
60. Ossip-Klein DJ, Doyne EJ, Bowman ED, Osborn KM, Mcdougall-Wilson IB, Neimeyer RA. Effects of running or weight lifting on self-concept in clinically depressed women. Journal of Consulting and Clinical Psychology 1989; 57: 158–161.
61. Foley LS, Prapavessis H, Osuch EA, De Pace JA, Murphy BA, Podolinsky NJ. An examination of potential mechanisms for exercise as a treatment for depression: a pilot study. Mental Health and Physical Activity 2008;1: 69–73.
62. Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of the effect of exercise on sleep. Sleep 1997; 20: 95–101. PubMed
63. Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stressinduced (neuro)inflammation, apoptosis and reduced neurogen-esis are associated to the onset of depression. Prog. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(3):744-59.
64. Wager-Smith K, Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neurosci Biobehav Rev 2011; 35 (3):742–764.
65. Capuro L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther 2011;130 (2):226–238. PubMed
66. García-Bueno B, Caso JR, Leza JC. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Neurosci Biobehav Rev 2008;32(6):1136-51.
67. García-Bueno B, Caso JR, Leza JC. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev 2008;32(6):1136-51.
68. Dishman R, O'Connor P. Lessons in exercise neuro-biology: the case of endorphins. Mental Health and Physical Activity 2009; 2: 4–9.
69. Broocks A, Meyer T, Opitz M, Bartmann U, Hillmer-Vogek U, George A, Pekrun G, Wedekind D, Ruther E, Bandelow B. 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo. European Neuropsychopharmacology 2003;13:153–164.
70. Ernst C, Olson A, Pinel J, Lam R, Christie B. Antidepressant effects of exercise: evidence for an adult-neu-rogenesis hypothesis? Journal of Psychiatry & Neuroscience 2006;31:84–92. PubMed
71. Lucassen P, Meerlo P, Naylor A, Van Dam A, Dayer A, Fuchs E, Oomen, C, Czeh B. Regulation of adult neu-rogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. European Neuropsychopharmacology 2010; 20:1–17.